Sunday 26 November 1400 - 1530
'New Insights: The role of statin therapy in stroke prevention'

For further information contact:
Caroline Sanders, PPSI Meetings Services,
3 Liverpool Gardens, Worthing West Sussex, BN11 1TF UK
Telephone: +44 1903 703027
Facsimile: +44 1903 703001

Sunday November 26 1600 - 1730
'Prevention and treatment of stroke in the new millennium'

For further information contact:
Peter Koetsier, Associate Director Metabolics
PO Box 39, Noble Park Victoria 3174 Australia
Telephone: +61 3 9213 4000
Facsimile: +61 3 9701 1526

"Is there more to preventing stroke in the elderly
than just blood pressure control"

Venue: World Convention Center, LaTrobe Theatre
Tuesday November 28, 2000, 12.30 to 2.00 p.m.

Co-Chairmen: Professor Geoffrey Donnan (AUS) and Professor Mark Dyken (USA)

Welcome and introduction G. Donnan (AUS) 12:30-12:35

Anti-hypertensive therapy, Stroke & the Elderly: Lessons from SYST-EUR plus INSIGHT
N.G. Wahlgren (Sweden) 12:35-12:50

The managment of the elderly at risk for stroke
H.J.M. Barnett (CDN) 12:50-13:05

Treatment of endothelial dysfunction in hypertension
A. Salvetti (Italy) 13:05-13:20

Hyperlipidemia, Stroke & Dementia: Preliminary Evidence for a NewTherapeutic Goal ?
P. Amarenco (France) 13:20-13:35

RESPECT: background rationale, design & status
M. Hennerici (Germany) 13:35-13:50

Concluding remarks & Discussion
M. Dyken (USA) 13:50-14:00

For further information contact:
Bayer AG Ph-PD SPM Lipobay
Markus Rupp/Neil Smith
Aprather Weg D-42096 Wuppertal
Telephone: +49 202 36 4111
Facsimile: +49 202 36-8412

Monday November 27 1730 - 1900
'The emerging role of neuroprotectants in the management of acute stroke'

For further information contact:
Lena Bruhn, Special Projects Neuroprotection
International Marketing
AstraZeneca, S-151 85 Södertälje, Sweden
Telephone: +46 8 553 260 00
Facsimile: +46 8 553 2888

Intima-Media Thickness, Drugs and Stroke

Saturday 25 November - Sunday 26 November

For further information contact:
Mark Portier at: ICA/JCD Conseil, 75014 Paris, France, email: mportier@jcdconseil.com

Further information can be obtained from
IMAGES Co-ordinating Centre, Dept. of Medicine & Therapeutics,
Western Infirmary, Glasgow, G11 6NT, Scotland.
Telephone: +44 141 211 2474
Facsimile: +44 141 211 6312

Inquiries:
Julien Bogousslavsky
Neurology Department
CHUV - BH 13
CH-1011 Lausanne, Switzerland
Phone: +41 21 314 12 20
Fax: +41 21 314 12 31
email: Julien.Bogousslavsky@chuv.hospvd.ch

All existing collaborators' and others interested in taking part in IST-3 or FOOD are cordially invited to attend. Tea, coffee and soft drinks will be available at 1700.

FOOD Trial: 1720 - 1740
Dr Graeme Hankey will summarise the trial and give an update on progress and methods to improve recruitment. This session will conclude with time for discussion.

IST-3: 1740 - 1820
Dr Richard Lindley will summarise the IST-3 protocol, give a progress report on the start-up phase and outline plans for the future. There will be plenty of time for questions and discussion.

After the IST-3 session we hope you will join us for drinks and canapés.